QIAGEN OmicSoft and Biomedical Knowledge Base

Checkpoint inhibitors in the context of biomarkers, drug targets and pathways

18 views
May 11, 2023
In this training, we will focus on how you can use QIAGEN Omicsoft Studio and QIAGEN Ingenuity Pathway Analysis (IPA) to discover new biomarkers, validate (or study) drug targets and identify novel mechanisms of action with your own and/or public checkpoint inhibitor datasets from resources like GEO, SRA, TCGA and more.

In this training, you’ll learn how to:

· Investigate the expression of a gene/biomarker/drug target across different treatments and diseases

· Derive a biomarker/gene signature from a specific condition (for example, non-responders of a drug, or a particular disease/disease subtype and others)

· Correlate expression of multiple genes and biomarkers

· Compare different experimental groups (e.g., your own data and/or public data) at both the levels of gene expression and pathways/regulatory networks activity

Related videos

QIAGEN OmicSoft and Biomedical Knowledge Base

Biomarker discovery and disease pathology investigation using OmicSoft and Ingenuity Pathway...

73 views March 16, 2023

In this training, attendees will learn how to harness curated ‘omics...

QIAGEN OmicSoft and Biomedical Knowledge Base

Drug treatment data investigation using Omicsoft and Ingenuity Pathway Analysis

44 views March 16, 2023

In this training, the trainer will go over how to utilize public drug...

QIAGEN OmicSoft and Biomedical Knowledge Base

Investigating biomarkers and drug targets from public data using QIAGEN Omicsoft Diseaseland and...

76 views February 17, 2023

In this 90-minute webinar, we’ll cover how to easily query non-oncology...

QIAGEN OmicSoft and Biomedical Knowledge Base

Discoveries from public immuno-oncology studies using Omicsoft and Ingenuity Pathway Analysis

91 views January 12, 2023

This training will focus on how QIAGEN Omicsoft Studio and Ingenuity Pathway...